Sichuan Huiyu Pharmaceutical (688553.SS) Earnings Analysis

Sichuan Huiyu Pharmaceutical (688553.SS) has no confirmed upcoming earnings date. Trailing P/E 153.49.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 688553.SS next report earnings?

No confirmed upcoming earnings date is currently scheduled for 688553.SS. This page updates as the calendar is published.

688553.SS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-270.0775 CNYn/an/an/a
2025-10-300.0712 CNYn/an/an/a
2025-08-30-0.13 CNYn/an/an/a
2025-04-250.0516 CNYn/an/an/a
2025-02-270.23 CNYn/an/an/a

688553.SS valuation and analyst view

Trailing P/E153.49
Trailing EPS0.05499 CNY
Price / book1.21
Dividend yield1.85%
Market cap6.94B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Sichuan Huiyu Pharmaceutical (688553.SS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 688553.SS. This page updates as the calendar is published.

Did 688553.SS beat earnings last quarter?

Consensus estimate data was not available for 688553.SS's 2026-02-27 report.

What is 688553.SS's current P/E ratio and EPS?

688553.SS trades at a trailing P/E of 153.49 on trailing EPS of 0.054993911709159585 CNY.

What do analysts rate 688553.SS?

688553.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.